Document is current

Any future updates will be listed below

Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease

Crossref DOI link: https://doi.org/10.1007/s00277-025-06202-7

Published Online: 2025-01-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark